Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.70 |
| ▸ | CA2 | P00918 | 2/20 | 0.70 |
| ▸ | CA9 | Q16790 | 2/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | PPARG | P37231 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.47 |
| ▸ | AGXT | P21549 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15903702 | 0.84 | CA1 (0.52) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL1395608 | 0.83 | CA2 (0.66) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL17318166 | 0.83 | CA1 (0.66) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL29669681 | 0.83 | CA1 (0.66) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL9750123 | 0.83 | CA2 (1.00) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL1593352 | 0.83 | CA1 (0.66) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL7291218 | 0.83 | CA1 (0.66) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL31194960 | 0.83 | CA2 (1.00) | CA1CA2CA9TDP1L3MBTL1 | |
| SCHEMBL974456 | 0.81 | CA2 (0.63) | CA1CA2CA9TDP1L3MBTL1 | |
| Potassium Ion SCHEMBL4610789 | 0.81 | CA2 (0.63) | CA1CA2CA9TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025065506-A1 | BENZYLAMINE COMPOUND, SYNTHESIS METHOD THEREFOR, AND USE THEREOF | 肇庆学院 | 2025-04-03 | — | — | WO | claimed |
| CN-119523898-A | Nasal administration preparation of multi-target medicine and application thereof | 肇庆学院 | 2025-02-28 | — | — | CN | claimed |
| WO-2022089499-A1 | PREFERRED METHOD OF USING LEVALBUTEROL SULFATE FOR THE TREATMENT OF RESPIRATORY DISEASES | 苏州君宁新药开发中心有限公司 | 2022-05-05 | — | — | WO | claimed |
| WO-2022057839-A1 | USE OF DRY POWDER INHALATION FORMULATION PREPARED FROM LEVOSALBUTAMOL SULFATE | 苏州君宁新药开发中心有限公司 | 2022-03-24 | — | — | WO | claimed |
| CN-108997261-B | Compound and preparation method and application thereof | 东莞市凯法生物医药有限公司 | 2022-01-07 | — | — | CN | claimed |
| EP-3911737-A1 | ENGINEERED ARYL SULFATE-DEPENDENT ENZYMES | Optimvia, LLC (US) | 2021-11-24 | — | — | EP | claimed |
| CN-113646427-A | Engineered arylsulfate-dependent enzymes | 奥普蒂姆维亚有限公司 | 2021-11-12 | — | — | CN | claimed |
| CN-113117080-A | Delivery of beta to brain2Methods of adrenergic receptor agonists | 珠海沅芷健康科技有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-112691088-A | Method for delivering levalbuterol to lung by inhalation of dry powder | 苏州君宁新药开发中心有限公司 | 2021-04-23 | — | — | CN | claimed |
| CN-112535668-A | A preferred method of using levalbuterol sulfate for the treatment of respiratory disorders | 苏州君宁新药开发中心有限公司 | 2021-03-23 | — | — | CN | claimed |
| WO-2020150350-A1 | ENGINEERED ARYL SULFATE-DEPENDENT ENZYMES | OPTIMVIA, LLC (US) | 2020-07-23 | — | — | WO | claimed |
| CN-104606177-A | Drug application of levo (R) salbutamol preparation in treatment of skin and mucous membrane traumatic ulcer | SUZHOU JUNNING NEW MEDICINE DEV CT CO LTD | 2015-05-13 | — | — | CN | claimed |
| CN-104069497-A | Composition and method for reducing drug tolerance and application thereof | DONGGUAN KAIFA BIOLOG MEDICINE CO LTD | 2014-10-01 | — | — | CN | claimed |
| EP-0531537-B1 | HIRUDIN ANALOGUE OR SALT THEREOF, PRODUCTION THEREOF, AND ANTICOAGULANT CONTAINING THE SAME AS ACTIVE INGREDIENT | JAPAN ENERGY CORP (JP) | 1996-09-11 | — | — | EP | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| EP-0531537-A1 | HIRUDIN ANALOGUE OR SALT THEREOF, PRODUCTION THEREOF, AND ANTICOAGULANT CONTAINING THE SAME AS ACTIVE INGREDIENT | JAPAN ENERGY CORPORATION (JP) | 1993-03-17 | — | — | EP | claimed |
| EP-3593390-B1 | FILM ELECTRODE, RESIN LAYER FORMING INK AND ELECTRODE PRINTING METHOD | RICOH CO LTD (JP) | 2025-09-17 | — | — | EP | disclosed |
| EP-4567936-A2 | FILM ELECTRODE, RESIN LAYER FORMING INK AND ELECTRODE PRINTING METHOD | Ricoh Company, Ltd. (JP) | 2025-06-11 | — | — | EP | disclosed |
| WO-1991005872-A1 | ENHANCED CHEMILUMINESCENT ASSAY | BRITISH TECHNOLOGY GROUP LTD (GB) | 1991-05-02 | — | — | WO | disclosed |
| US-4684681-A | Flow enhanced polyphenylene ether resin compositions | GENERAL ELECTRIC COMPANY (US) | 1987-08-04 | — | — | US | disclosed |